🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Bingshu E. Chen

Canadian Cancer Society

ORCID: 0000-0001-6139-0696

Also affiliated with Queen's University, Queens University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.104Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00733-y
Top 78%
0.104DataRank
Top 78%1 citations

Stefan Winter, Wing‐Yee Lo, Kyriaki Michailidou, Manjeet K. Bolla, Renske Keeman +69 more

Papers

Driven by 5 papers — median percentile 22. Top paper: “Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α”.

Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3091
N/A
1.4DataRank · unranked
41 citations

Junmei Cairns, Vera J. Suman, Lois E. Shepherd, Peter A. Fasching, Tanya L. Hoskin +19 more

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00733-y
Top 78%
0.104DataRank
Top 78%1 citations

Stefan Winter, Wing‐Yee Lo, Kyriaki Michailidou, Manjeet K. Bolla, Renske Keeman +69 more

A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia

Clinical Lymphoma Myeloma & Leukemia(2021)10.1016/j.clml.2021.06.011
N/A
0DataRank · unranked
5 citations

Nicole Mittmann, Carolyn Owen, Nizar Abdel‐Samad, Graeme Fraser, Selay Lam +15 more

Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin versus placebo in hormone receptor–positive early-stage breast cancer (CCTG MA32).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.526
N/A
0DataRank · unranked
0 citations

Bingshu E. Chen, Wendy R. Parulekar, Julie Lemieux, Jennifer A. Ligibel, Karen A. Gelmon +3 more

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials

The Lancet(2023)10.1016/s0140-6736(23)00285-4
N/A
0DataRank · unranked
195 citations

Rosie Bradley, Richard Gray, Robert K. Hills, Hongchao Pan, Richárd Pető +95 more